MVX-1 loaded autologous tumour vaccine (MaxiVax)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMVX-1 loaded autologous tumour vaccine (MaxiVax)
Drug Alias NameMaxiVax vaccineMVX-1-loaded macrocapsule/autologous tumour cell vaccineMVX-ONCO-1
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionGranulocyte-macrophage colony-stimulating factor receptor stimulantsImmunostimulants
TargetsGranulocyte-macrophage colony-stimulating factor receptor
Therapy Area/IndicationsHead and Neck Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMaxivax Sa
China Registration ClassN/A

Develop Information

Active CompaniesMaxivax Sa
Inactive CompaniesN/A
Active IndicationsHead and Neck Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A